[go: up one dir, main page]

NO20083276L - Behandling av diabetes med tiazolidindion og sulfonylurea - Google Patents

Behandling av diabetes med tiazolidindion og sulfonylurea

Info

Publication number
NO20083276L
NO20083276L NO20083276A NO20083276A NO20083276L NO 20083276 L NO20083276 L NO 20083276L NO 20083276 A NO20083276 A NO 20083276A NO 20083276 A NO20083276 A NO 20083276A NO 20083276 L NO20083276 L NO 20083276L
Authority
NO
Norway
Prior art keywords
thiazolidinedione
sulfonylurea
diabetes
treatment
mammal
Prior art date
Application number
NO20083276A
Other languages
English (en)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26311744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083276(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9712854.0A external-priority patent/GB9712854D0/en
Priority claimed from GBGB9806710.1A external-priority patent/GB9806710D0/en
Publication of NO20083276L publication Critical patent/NO20083276L/no
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for behandling av diabetes mellitus og tilstander assosiert med diabetes mellitus hos et pattedyr, som omfatter administrering av en effektiv ugiftig og farmasøytisk godtagbar mengde av en insulinsensibilisator og et insulinutskillende middel, til et pattedyr med behov for dette.
NO20083276A 1997-06-18 2008-07-24 Behandling av diabetes med tiazolidindion og sulfonylurea NO20083276L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712854.0A GB9712854D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806710.1A GB9806710D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003688 WO1998057649A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (1)

Publication Number Publication Date
NO20083276L true NO20083276L (no) 2000-02-17

Family

ID=26311744

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19996264A NO326263B1 (no) 1997-06-18 1999-12-17 Kombinasjon omfattende tiazolidindion og sulfonylurea, anvendelse derav, samt farmasoytisk sammensetning
NO20083276A NO20083276L (no) 1997-06-18 2008-07-24 Behandling av diabetes med tiazolidindion og sulfonylurea
NO2009002C NO2009002I1 (no) 1997-06-18 2009-02-13 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19996264A NO326263B1 (no) 1997-06-18 1999-12-17 Kombinasjon omfattende tiazolidindion og sulfonylurea, anvendelse derav, samt farmasoytisk sammensetning

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2009002C NO2009002I1 (no) 1997-06-18 2009-02-13 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid

Country Status (33)

Country Link
EP (3) EP0999845B1 (no)
JP (1) JP2001523270A (no)
KR (3) KR20070011651A (no)
CN (1) CN1168451C (no)
AP (1) AP1600A (no)
AR (2) AR012996A1 (no)
AT (1) ATE353654T1 (no)
AU (1) AU8539298A (no)
BG (2) BG109397A (no)
BR (1) BR9810142A (no)
CA (1) CA2294385C (no)
CO (1) CO4940457A1 (no)
CZ (1) CZ299310B6 (no)
DE (1) DE69837089T2 (no)
DZ (1) DZ2522A1 (no)
EA (1) EA003025B1 (no)
ES (1) ES2283064T3 (no)
ID (1) ID24065A (no)
IL (1) IL133137A (no)
IN (1) IN189319B (no)
MA (1) MA24571A1 (no)
MY (1) MY125855A (no)
NO (3) NO326263B1 (no)
NZ (1) NZ501163A (no)
OA (1) OA11510A (no)
PE (1) PE108199A1 (no)
PL (2) PL337510A1 (no)
SK (1) SK286028B6 (no)
TR (1) TR199903096T2 (no)
TW (1) TW542717B (no)
UA (1) UA67743C2 (no)
UY (1) UY25048A1 (no)
WO (1) WO1998057649A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
ATE247653T1 (de) 1999-04-23 2003-09-15 Smithkline Beecham Plc Thiazolidindionderivat und seine verwendung als antidiabetikum
US7166584B1 (en) 1999-11-01 2007-01-23 Wisconsin Alumni Research Foundation Cholesterol transport gene
BRPI0206432A2 (pt) 2001-01-12 2016-10-25 Sun Pharmaceutical Ind Ltd métodos para administrar dois ou mais agentes terapêuticos ativos e para tratar diabetes melito ou sintomas associados com diabetes melito em um humano e sistema de liberação espaçada de medicamento
KR100698595B1 (ko) * 2003-09-29 2007-03-21 보령제약 주식회사 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물
PT1677792E (pt) * 2003-10-31 2016-02-09 Takeda Pharmaceutical Preparação sólida compreendendo pioglitazona, glimepirida e um éster de ácido gordo de polioxietileno sorbitano
RU2426530C2 (ru) 2005-12-22 2011-08-20 Такеда Фармасьютикал Компани Лимитед Твердый препарат
CN104158867B (zh) * 2014-08-06 2017-05-17 电子科技大学 一种基于wave协议的信息多跳转发方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US4791125A (en) 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1989008650A1 (en) 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
CA2086606A1 (en) 1990-07-03 1992-01-04 Kunihiro Niigata Bisheterocyclic compound
DE69106714T2 (de) 1990-08-23 1995-05-11 Pfizer Hypoglykämische hydroxyharnstoffderivate.
JPH04210683A (ja) 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
AU1743292A (en) 1991-04-11 1992-11-17 Takeda Chemical Industries Ltd. Thiazolidinedione derivatives, production and use thereof
US5183823A (en) 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
TW222626B (no) 1991-07-22 1994-04-21 Pfizer
FR2680512B1 (fr) 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
JPH05271204A (ja) 1992-03-26 1993-10-19 Japan Tobacco Inc 新規なトリアジン誘導体
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
WO1993021166A1 (en) 1992-04-10 1993-10-28 Smithkline Beecham Plc Heterocyclic compounds and their use in the treatment of type ii-diabetes
AU4104593A (en) 1992-05-05 1993-11-29 Upjohn Company, The A process for producing pioglitazone metabolite
EP0648212B1 (en) 1992-07-03 2001-10-24 Smithkline Beecham Plc Benzoxazole and benzothiazole derivatives as pharmaceutical
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
PL198018B1 (pl) 2008-05-30
BG104058A (en) 2000-10-31
CO4940457A1 (es) 2000-07-24
TW542717B (en) 2003-07-21
IN189319B (no) 2003-02-08
AU8539298A (en) 1999-01-04
EP0999845B1 (en) 2007-02-14
OA11510A (en) 2004-02-03
AP1600A (en) 2006-04-28
SK286028B6 (sk) 2008-01-07
ID24065A (id) 2000-07-06
DZ2522A1 (fr) 2003-02-01
CA2294385A1 (en) 1998-12-23
TR199903096T2 (xx) 2000-08-21
AR012996A1 (es) 2000-11-22
UY25048A1 (es) 2000-09-29
KR20010013840A (ko) 2001-02-26
KR20070011651A (ko) 2007-01-24
BR9810142A (pt) 2000-08-08
MY125855A (en) 2006-08-30
UA67743C2 (uk) 2004-07-15
EP0999845A1 (en) 2000-05-17
IL133137A (en) 2004-02-08
CA2294385C (en) 2007-06-05
ES2283064T3 (es) 2007-10-16
EP1671637A2 (en) 2006-06-21
EP1671637A3 (en) 2007-12-19
CZ9904577A3 (en) 2001-05-16
DE69837089T2 (de) 2007-06-21
AR008025A1 (es) 1999-12-09
WO1998057649A1 (en) 1998-12-23
CN1168451C (zh) 2004-09-29
SK179199A3 (en) 2000-11-07
PE108199A1 (es) 2000-01-14
AP9901717A0 (en) 1999-12-31
NO2009002I1 (no) 2009-03-02
KR20080011356A (ko) 2008-02-01
EP2266576A1 (en) 2010-12-29
DE69837089D1 (de) 2007-03-29
PL337510A1 (en) 2000-08-28
IL133137A0 (en) 2001-03-19
EA003025B1 (ru) 2002-12-26
NO326263B1 (no) 2008-10-27
CN1260719A (zh) 2000-07-19
HK1028200A1 (en) 2001-02-09
EA200000039A1 (ru) 2000-08-28
NZ501163A (en) 2002-02-01
MA24571A1 (fr) 1998-12-31
NO996264D0 (no) 1999-12-17
BG64817B1 (bg) 2006-05-31
ATE353654T1 (de) 2007-03-15
BG109397A (bg) 2006-05-31
CZ299310B6 (cs) 2008-06-18
NO996264L (no) 2000-02-17
JP2001523270A (ja) 2001-11-20

Similar Documents

Publication Publication Date Title
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
ZA984798B (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome gestational diabetes and disease states at risk for progressing to noninsulindependent diabetes mellitus
NO970519L (no) Behandling av type II diabetes mellitus med amylinagonister
CA2071629A1 (en) Use of insulin sensitizing agents to treat hypertension
LU92613I2 (fr) Saxagliptin et ses dérivés pharmaceutiquement acceptables (ONGLYZA)
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
DK1572230T3 (da) Placenta alkalisk phosphatase til at kontrollere diabetes
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
NO992062L (no) Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
NO996270L (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
NO20000230L (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og &lt;alfa&gt;glukosidaseinhibitor
EA200000141A1 (ru) Способ лечения диабета тиазолидиндионом и сульфонилмочевиной
RU96115219A (ru) Способ лечения больных сахарным диабетом
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
RU94010369A (ru) Способ получения производных инсулина
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
AU6102801A (en) Method of preventing or treating diabetes
ECSP982593A (es) Nuevo metodo de tratamiento vi
ECSP982535A (es) Nuevo metodo de tratamiento (i)
RU99102083A (ru) Способ профилактики рецидивов язвенной болезни двенадцатиперстной кишки

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application